| Literature DB >> 28966330 |
Takeshi Hayashi1,2, Hirotaka Shibata3, Isao Kurihara1, Kenichi Yokota1, Yuko Mitsuishi1, Kennosuke Ohashi2, Ayano Murai-Takeda1, Rie Jo1, Takako Ohyama1, Masaya Sakamoto2, Katsuyoshi Tojo2, Naoko Tajima2, Kazunori Utsunomiya2, Hiroshi Itoh1.
Abstract
Activation of mineralocorticoid receptor (MR) is shown in resistant hypertension including diabetes mellitus. Although protein kinase C (PKC) signaling is involved in the pathogenesis of diabetic complications, an association between PKC and MR is not known. Activation of PKCα and PKCβ by TPA (12-O-Tetradecanoylphorbol 13-acetate) increased MR proteins and its transcriptional activities in HEK293-MR cells. In contrast, a high glucose condition resulted in PKCβ but not PKCα activation, which is associated with elevation of MR protein levels and MR transcriptional activities. Reduction of endogenous PKCβ by siRNA decreased those levels. Interestingly, high glucose did not affect MR mRNA levels, but rather decreased ubiquitination of MR proteins. In db/db mice kidneys, levels of phosphorylated PKCβ2, MR and Sgk-1 proteins were elevated, and the administration of PKC inhibitor reversed these changes compared to db/+ mice. These data suggest that high glucose stimulates PKCβ signaling, which leads to MR stabilization and its transcriptional activities.Entities:
Keywords: Diabetes mellitus; Diabetic complication; Resistant hypertension
Mesh:
Substances:
Year: 2017 PMID: 28966330 DOI: 10.1536/ihj.16-649
Source DB: PubMed Journal: Int Heart J ISSN: 1349-2365 Impact factor: 1.862